Nur 6011 - Mod 1 - reply 1 Group A HTN

docx

School

William Paterson University *

*We aren’t endorsed by this school

Course

6011

Subject

Computer Science

Date

Apr 3, 2024

Type

docx

Pages

2

Uploaded by PresidentPorpoise3618

Report
Hypertension - Group A Question KF is a 62 yo Caucasian male diagnosed with hypertension. He has had a BP in the high 170s/high 80’s for several months. All labs have been normal. What medication(s) would you initiate therapy and why? What medication(s) would your choice be if the patient were African American and why? For all medications discussed please discuss the medications mechanism of action in treating HTN. For all medications discussed please explain the monitoring parameters of efficacy and side effects. My Response to Group A: Hello Asley. Great post; your breakdown of HTN medications and their mechanisms was spot on. My husband takes olmesartan, an angiotensin II receptor blocker. We monitor his blood pressure, not every day, but weekly, and thankfullly he never had an adverse reaction. My father-in-law was diagnosed with HTN and type two diabetes early in his life. He was on lisinopril, an angiotensin-converting enzyme (ACE) inhibitor for his HTN and metformin, a biguanide, for his diabetes. He had to monitor his blood pressure and sugars daily and I don’t recall him having any adverse reactions either. However, he took his medications daily but never at the same time and he never took Metformin before meals. I explained the effectiveness and the reason behind it, that it would lower blood sugar levels by reducing the amount of glucose produced by the liver, but he didn’t adhere to the doctor’s recommendation either. I was reading an article entitled, “Association between medication adherence and quality of life (Qol) of patients with diabetes and hypertension attending primary care clinics: a cross-sectional survey” and found the following interesting: The survey was to evaluate the association between medication adherence and quality of life of patients with diabetes and/or hypertension attending primary care clinics. There is an association between medication adherence and QoL among patients with diabetes and/or hypertension attending primary care clinics. Medication adherence should be assessed and emphasized during routine clinical consultations in primary care in order to achieve the desired clinical outcomes and overall well-being of patients. (Khayyat et al., 2019) Preferred antihypertensive drugs in patients with diabetes are angiotensin-converting enzyme, angiotensin receptor blockers, calcium channel blockers, and diuretics (in low doses). In patients with diabetic nephropathy, ACEIs and ARBs can slow the progression of renal damage and reduce albuminuria. It is important to note, however, that beta blockers can suppress glycogenolysis and mask early signs of hypoglycemia; therefore they must be used with caution. Thiazides and loop diuretics promote hyperglycemia and hence should also be used with caution. (Rosenthal & Burchum, 2020, p. 321)
References Khayyat, S. M., Mohamed, M. M., Saeed-Khayyat, S. M., & Hyat-Alhazmi, R. S. (2019). Association between medication adherence and quality of life (Qol) of patients with diabetes and hypertension attending primary care clinics: a cross-sectional survey. Quality of Life Research , 28 , 1053-1061. https://doi.org/10.1007/s11136-018-2060-8 Rosenthal, L. D., & Burchum, J. R. (2020). Lehne's Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants . Elsevier.
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help